Neurocrine has offered $53 per Soleno share held, which represents a premium of about 34% to the stock’s last close.
Source: US Top News and Analysis
Related Posts
Budget airlines built on cheap fares now face a painful reality: Fuel is getting expensive
Budget airlines try to maintain low costs while fuel costs continue to rise Source: US…
SpaceX confidentially files for IPO, setting stage for record offering
Elon Musk’s SpaceX is reportedly targeting a valuation of around $1.75 trillion in its forthcoming…
Stocks had a massive rally to end March. Why they’re still not out of the woods
The stock market’s rip higher may not signal the all-clear investors are looking for. Source:…